For over a quarter century, SSCI has been the first choice for pharmaceutical companies seeking to improve drug substance and drug product performance. SSCI has worked on more active pharmaceutical ingredients and drug products than any other solid-state contract research organization. We leverage our product development skills to assist our law firm and corporate law clients to understand the “science behind the IP” to construct claims, perform infringement analyses, evaluate inherent anticipation positions, and perform experiments at our state-of-the-art FDA-validated cGMP facility.
All of the scientific muscle of SSCI, now a division of AMRI, is available to our Expert Services group which coordinates and works closely with our clients to assist in the patent procurement or litigation. We act as testifying and non-testifying experts in patent litigation worldwide and our scientists have been deposed, cross-examined and have testified in proceedings throughout the world.
We have also been called upon to assist in highly-technical patent prosecution matters in the United States and abroad. Whether testifying by declaration in the United States or giving oral testimony at European Opposition, SSCI scientists have unparalleled scientific experience which, coupled with access to our world-class facility, enables them to bring unique resources, not found anywhere else, to bear to solve complex science-based patent issues.
SSCI has been involved in hundreds of litigation matters worldwide as expert and fact witnesses and have helped numerous clients obtain patent protection on their solid-state chemical inventions. What also differentiates us from the pack is that our scientists continue to innovate and conduct research so that the techniques and methods we apply in litigation are the same ones we develop and use in the laboratory to help our pharmaceutical customers bring their innovations to market.